http://prostatecancerinfolink.net/2010/12/29/second-study-confirms-data-on-p
sadt-and-survival-post-surgery/
* Only PSA doubling time (™9.0 months vs 3.0-8.9 months vs < 3.0
months) remained independently predictive of overall and/or metastasis-free
survival in multivariate analysis.
The authors note that - based on this data set - overall and metastasis-free
survival "can be extensive for men with PSA-recurrent prostate cancer, even
in the absence of further therapy before metastasis."
In other words, men with a PSA doubling time > 9 months after initial
biochemical failure have a high probability of long-term metastasis-free
survival, which may call into question the value of any form of second-line
therapy until there is clear evidence of the presence of metastatic disease.
Link is also available on the VPCC Facebook page.
I have this form of prostate cancer, so it's nice to know that I will not have to turn seriously to hormone therapy. This does not mean that I no longer need any drugs or other agents, however. I still take minimum dose Avodart(dutastaride), and also a mild dose of Casodex:2 50mm tablets each week. Adding to my regimen are Vitamin D3(8,000IU daily), promegranate capsules, Super Bio-Curcumin, Reveratrol (100 mm daily), omega gentsa. I also exercise regularly. Staying healthy remains important
ReplyDeleteDick Gillespie
Hi to All,
ReplyDeleteMy Avodart, minimum dose(0.5mm) is taken daily.
Dick G